Demand for the twice-a-year HIV prevention jab is outpacing supply, Health Department warns as the first return injections fall due
Uptake of lenacapavir, the twice-yearly HIV prevention injection launched in June, is strong, but the national Health Department says supplies tied to Global Fund allocations fall well short of demand. The jab is available at 360 public clinics in 24 districts across six provinces, and the first follow-up injections fall due from 20 November.
South Africa’s rollout of lenacapavir, the long-acting injection that protects against HIV with just two doses a year, has run into a familiar problem: more people want it than the country can currently supply.
Strong uptake
Deputy Health Minister Joe Phaahla said uptake had been good in all six provinces where the injection is offered, with young people in particular coming forward, according to IOL’s Cape Times. “We are worried more about the availability of stock matching the demand,” he said, speaking on the sidelines of a meeting of Southern African Development Community (SADC) health ministers last week. The pressure, he said, was from people asking when the injection would reach the remaining provinces and districts.
Phaahla said the challenge was not only about money. Gilead, the main manufacturer, is still scaling up production, and companies licensed to make cheaper generic versions are at an early stage.
What the minister told Parliament
In a written parliamentary reply cited by IOL, Health Minister Aaron Motsoaledi confirmed rising demand since the national launch on 5 June, especially among women and key population groups, but flagged concerns about affordability until generics arrive. He said supplies depend on allocations from the Global Fund, which are well below national demand, and that access is limited to 360 public facilities in 24 districts.
The rollout currently covers Gauteng, KwaZulu-Natal, the Eastern Cape, Mpumalanga, North West and the Western Cape. The Free State, Limpopo and Northern Cape are due to follow in later phases.
Return visits start now
People who started on the injection are due for their second dose from 20 November, six months after the first. Motsoaledi said clinics have appointment and SMS reminder systems in place, and that everyone must test HIV-negative before each injection. Health workers at all 360 sites have been trained, and stock is being tracked through the department’s monitoring systems.
Why it matters
South Africa has the world’s largest HIV epidemic, and a twice-yearly jab removes the need to take a daily prevention pill. Its value depends on people getting their follow-up dose on time, which is why steady supply matters as much as uptake.
Related: MPs press Motsoaledi over the R12.6bn ARV tender
Sources
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0
Comments (0)